115 related articles for article (PubMed ID: 10712293)
1. Sucrose consumption increases naloxone-induced c-Fos immunoreactivity in limbic forebrain.
Pomonis JD; Jewett DC; Kotz CM; Briggs JE; Billington CJ; Levine AS
Am J Physiol Regul Integr Comp Physiol; 2000 Mar; 278(3):R712-9. PubMed ID: 10712293
[TBL] [Abstract][Full Text] [Related]
2. Expression of Fos during sham sucrose intake in rats with central gustatory lesions.
Mungarndee SS; Lundy RF; Norgren R
Am J Physiol Regul Integr Comp Physiol; 2008 Sep; 295(3):R751-63. PubMed ID: 18635449
[TBL] [Abstract][Full Text] [Related]
3. c-Fos and peptide immunoreactivities in the central extended amygdala of morphine-dependent rats after naloxone-precipitated withdrawal.
Veinante P; Stoeckel ME; Lasbennes F; Freund-Mercier MJ
Eur J Neurosci; 2003 Sep; 18(5):1295-305. PubMed ID: 12956728
[TBL] [Abstract][Full Text] [Related]
4. Regional differences in naloxone modulation of Delta(9)-THC induced Fos expression in rat brain.
Allen KV; McGregor IS; Hunt GE; Singh ME; Mallet PE
Neuropharmacology; 2003 Feb; 44(2):264-74. PubMed ID: 12623225
[TBL] [Abstract][Full Text] [Related]
5. Dissection of peripheral and central endogenous opioid modulation of systemic interleukin-1beta responses using c-fos expression in the rat brain.
Buller KM; Hamlin AS; Osborne PB
Neuropharmacology; 2005 Aug; 49(2):230-42. PubMed ID: 15993445
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the hypothalamic paraventricular nucleus and central nucleus of the amygdala in naloxone blockade of neuropeptide Y-induced feeding revealed by c-fos expression.
Pomonis JD; Levine AS; Billington CJ
J Neurosci; 1997 Jul; 17(13):5175-82. PubMed ID: 9185555
[TBL] [Abstract][Full Text] [Related]
7. Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.
Frenois F; Cador M; Caillé S; Stinus L; Le Moine C
Eur J Neurosci; 2002 Oct; 16(7):1377-89. PubMed ID: 12405997
[TBL] [Abstract][Full Text] [Related]
8. The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine.
Rohde DS; McKay WR; Chang DS; Abbadie C; Basbaum AI
Neuroscience; 1997 Sep; 80(2):599-612. PubMed ID: 9284361
[TBL] [Abstract][Full Text] [Related]
9. Swim-stress but not opioid withdrawal increases expression of c-fos immunoreactivity in rat periaqueductal gray neurons which project to the rostral ventromedial medulla.
Bellchambers CE; Chieng B; Keay KA; Christie MJ
Neuroscience; 1998 Mar; 83(2):517-24. PubMed ID: 9460759
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity to naloxone of the behavioral signs of morphine withdrawal and c-Fos expression in the rat CNS: a quantitative dose-response analysis.
Le Guen S; Gestreau C; Besson JM
J Comp Neurol; 2001 Apr; 433(2):272-96. PubMed ID: 11283964
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
[TBL] [Abstract][Full Text] [Related]
12. Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion.
Gracy KN; Dankiewicz LA; Koob GF
Neuropsychopharmacology; 2001 Feb; 24(2):152-60. PubMed ID: 11120397
[TBL] [Abstract][Full Text] [Related]
13. Naloxone effects on sucrose-motivated behavior.
Cleary J; Weldon DT; O'Hare E; Billington C; Levine AS
Psychopharmacology (Berl); 1996 Jul; 126(2):110-4. PubMed ID: 8856829
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats.
Nakagawa T; Yamamoto R; Fujio M; Suzuki Y; Minami M; Satoh M; Kaneko S
Neuroscience; 2005; 134(1):9-19. PubMed ID: 15939543
[TBL] [Abstract][Full Text] [Related]
15. Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system.
Le Guen S; Gestreau C; Besson JM
Eur J Neurosci; 2003 Jun; 17(11):2425-37. PubMed ID: 12814374
[TBL] [Abstract][Full Text] [Related]
16. Hedonic drinking engages a supraspinal inhibition of thermal nociception in adult rats.
Davies AJ; Kim D; Park J; Lee JY; Vang H; Pickering AE; Oh SB
Pain; 2019 May; 160(5):1059-1069. PubMed ID: 31008815
[TBL] [Abstract][Full Text] [Related]
17. Blunted hyperphagic and c-Fos immunoreactivity responsiveness to an orexigen, butorphanol tartrate, in aged rats.
Olszewski PK; McColl LK; Herisson FM; Klockars A; Levine AS
Neurosci Lett; 2019 Oct; 711():134409. PubMed ID: 31374323
[TBL] [Abstract][Full Text] [Related]
18. Neuroanatomical patterns of Fos-like immunoreactivity induced by naltrexone in food-restricted and ad libitum fed rats.
Carr KD; Park TH; Zhang Y; Stone EA
Brain Res; 1998 Jan; 779(1-2):26-32. PubMed ID: 9473572
[TBL] [Abstract][Full Text] [Related]
19. Naloxone potentiates treadmill running-induced increase in c-Fos expression in rat hippocampus.
Lee MH; Kim H; Lim BV; Chang HK; Lee TH; Jang MH; Shin MC; Lee J; Shin MS; Kim CJ
Life Sci; 2003 Oct; 73(24):3139-47. PubMed ID: 14550853
[TBL] [Abstract][Full Text] [Related]
20. Is there tonic activity in the endogenous opioid systems? A c-Fos study in the rat central nervous system after intravenous injection of naloxone or naloxone-methiodide.
Gestreau C; Le Guen S; Besson JM
J Comp Neurol; 2000 Nov; 427(2):285-301. PubMed ID: 11054694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
